Hemophilia natural history, complications and prognosis

Jump to: navigation, search

Hemophilia Microchapters


Patient Information


Historical Perspective




Differentiating Hemophilia from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Hemophilia natural history, complications and prognosis

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia natural history, complications and prognosis

CDC on Hemophilia natural history, complications and prognosis

Hemophilia natural history, complications and prognosis in the news

Blogs on Hemophilia natural history, complications and prognosis

Directions to Hospitals Treating Hemophilia

Risk calculators and risk factors for Hemophilia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]


Hemophilia can present with a bleeding episode during the neonatal period that is difficult to manage or it can present with signs and symptoms of concealed bleeding into the joint or viscera. If left untreated, hemophilia can result in complications involving multiple organs and in severe bleeding episodes it can result in death. Hemophilia patients can lead an active and healthy life and life expectancy depends on the treatment response and the presence of comorbidities. Complications of hemophilia include AIDS, hepatitis, Vitamin D deficiency, osteoporosis, and renal pathologies.

Natural History, Complications, and Prognosis

Natural History


Common complications of hemophilia include:



  1. 1.0 1.1 Mense L, Ferretti E, Ramphal R, Daboval T (September 2018). "A Newborn with Simmering Bleeding after Circumcision". Cureus. 10 (9): e3324. doi:10.7759/cureus.3324. PMC 6248866. PMID 30473957.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Mannucci PM, Tuddenham EG (June 2001). "The hemophilias--from royal genes to gene therapy". N. Engl. J. Med. 344 (23): 1773–9. doi:10.1056/NEJM200106073442307. PMID 11396445.
  3. Bolton-Maggs, Paula HB; Pasi, K John (2003). "Haemophilias A and B". The Lancet. 361 (9371): 1801–1809. doi:10.1016/S0140-6736(03)13405-8. ISSN 0140-6736.
  4. Roosendaal G, Lafeber FP (July 2006). "Pathogenesis of haemophilic arthropathy". Haemophilia. 12 Suppl 3: 117–21. doi:10.1111/j.1365-2516.2006.01268.x. PMID 16684006.
  5. 5.0 5.1 Berntorp E, Shapiro AD (April 2012). "Modern haemophilia care". Lancet. 379 (9824): 1447–56. doi:10.1016/S0140-6736(11)61139-2. PMID 22456059.
  6. 6.0 6.1 Kasper CK (March 2004). "AIDS, hepatitis and hemophilia". J. Thromb. Haemost. 2 (3): 516–8. PMID 15009473.
  7. Magallón Martínez M, Ortega F, Pinilla J (1992). "AIDS and hemophilia: experience in the La Paz Hemophilia Center". Haemostasis. 22 (5): 281–92. doi:10.1159/000216336. PMID 1362177.
  8. 8.0 8.1 Makris M, Konkle BA (March 2017). "Hepatitis C in haemophilia: time for treatment for all". Haemophilia. 23 (2): 180–181. doi:10.1111/hae.13183. PMID 28300362.
  9. Goodman, Catherine (2015). Pathology : implications for the physical therapist. St. Louis, Missouri: Elsevier Saunders. ISBN 9781455745913.
  10. Murphy N, O'Mahony B, Flanagan P, Noone D, White B, Bergin C, Norris S, Thornton L (September 2017). "Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre-DAA treatment era". Haemophilia. 23 (5): 712–720. doi:10.1111/hae.13244. PMID 28752601.
  11. 11.0 11.1 Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A (September 2002). "End-stage liver disease in persons with hemophilia and transfusion-associated infections". Blood. 100 (5): 1584–9. PMID 12176875.
  12. 12.0 12.1 Moreira A, Das H (2018). "Acute Life-Threatening Hemorrhage in Neonates With Severe Hemophilia A: A Report of 3 Cases". J Investig Med High Impact Case Rep. 6: 2324709618800349. doi:10.1177/2324709618800349. PMC 6144491. PMID 30246038.
  13. Loomans JI, Eckhardt CL, Reitter-Pfoertner SE, Holmström M, van Gorkom BL, Leebeek F, Santoro C, Haya S, Meijer K, Nijziel MR, van der Bom JG, Fijnvandraat K (June 2017). "Mortality caused by intracranial bleeding in non-severe hemophilia A patients". J. Thromb. Haemost. 15 (6): 1115–1122. doi:10.1111/jth.13693. PMID 28374963. Vancouver style error: initials (help)
  14. Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF (January 2017). "Pathophysiology of hemophilic arthropathy and potential targets for therapy". Pharmacol. Res. 115: 192–199. doi:10.1016/j.phrs.2016.11.032. PMID 27890816.
  15. Eldash HH, Atwa ZT, Saad MA (January 2017). "Vitamin D deficiency and osteoporosis in hemophilic children: an intermingled comorbidity". Blood Coagul. Fibrinolysis. 28 (1): 14–18. doi:10.1097/MBC.0000000000000519. PMID 26825623.
  16. Albayrak C, Albayrak D (April 2015). "Vitamin D levels in children with severe hemophilia A: an underappreciated deficiency". Blood Coagul. Fibrinolysis. 26 (3): 285–9. doi:10.1097/MBC.0000000000000237. PMID 25485786.
  17. 17.0 17.1 Kadir RA, Economides DL, Lee CA (January 1999). "Factor XI deficiency in women". Am. J. Hematol. 60 (1): 48–54. PMID 9883805.
  18. Tabriznia-Tabrizi S, Gholampour M, Mansouritorghabeh H (September 2016). "A close insight to factor VIII inhibitor in the congenital hemophilia A". Expert Rev Hematol. 9 (9): 903–13. doi:10.1080/17474086.2016.1208554. PMID 27367203.
  19. Ashrani AA, Key NS, Soucie JM, Duffy N, Forsyth A, Geraghty S (May 2008). "Septic arthritis in males with haemophilia". Haemophilia. 14 (3): 494–503. doi:10.1111/j.1365-2516.2008.01662.x. PMC 3951979. PMID 18298584.
  20. Olivier M, Madruga M, Carlan SJ, Ge L (2018). "Hemophilia A Complicated by Ulcerative Colitis". Case Rep Gastrointest Med. 2018: 2342618. doi:10.1155/2018/2342618. PMC 6142740. PMID 30298109.
  21. LEATHERDALE RA (April 1960). "Respiratory obstruction in haemophilic patients". Br Med J. 1 (5182): 1316–20. PMC 1967523. PMID 14414970.
  22. 22.0 22.1 Sharma R, Dash SK, Chawla R, Kansal S, Agrawal DK, Dua H (November 2013). "Acquired hemophilia complicated by cardiorenal syndrome type 3". Indian J Crit Care Med. 17 (6): 378–81. doi:10.4103/0972-5229.123456. PMC 3902575. PMID 24501492.
  23. Rawat J, Singh S, Chaubey D (August 2017). "Spontaneous bladder rupture: unusual presentation in a haemophilic child". BMJ Case Rep. 2017. doi:10.1136/bcr-2017-220943. PMID 28784897.
  24. Frioui S, Jemni S (2015). "[A rare muscular complication of hemophilia: Myositis ossificans]". Pan Afr Med J (in French). 22: 149. doi:10.11604/pamj.2015.22.149.7909. PMC 4742018. PMID 26889330.
  25. Freeman A (February 2015). "Acquired haemophilia A presenting at a District General Hospital". BMJ Case Rep. 2015. doi:10.1136/bcr-2014-208001. PMC 4336866. PMID 25691577.
  26. 26.0 26.1 Franchini M, Mannucci PM (July 2013). "Hemophilia A in the third millennium". Blood Rev. 27 (4): 179–84. doi:10.1016/j.blre.2013.06.002. PMID 23815950.
  27. Franchini M, Mannucci PM (December 2017). "Management of Hemophilia in Older Patients". Drugs Aging. 34 (12): 881–889. doi:10.1007/s40266-017-0500-8. PMID 29159733.
  28. Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR (March 2006). "Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study". J. Thromb. Haemost. 4 (3): 510–6. doi:10.1111/j.1538-7836.2006.01808.x. PMID 16460432.
  29. Rosendaal, F. R.; Varekamp, I.; Smit, C.; Bröcker-Vriends, A. H. J. T.; van Dijck, H.; Vandenbroucke, J. P.; Hermans, J.; Suurmeijer, T. P. B. M.; Briët, E. (1989). "Mortality and causes of death in Dutch haemophiliacs, 1973–86". British Journal of Haematology. 71 (1): 71–76. doi:10.1111/j.1365-2141.1989.tb06277.x. ISSN 0007-1048.
  30. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE (February 2009). "Cardiovascular disease in patients with hemophilia". J. Thromb. Haemost. 7 (2): 247–54. doi:10.1111/j.1538-7836.2008.03201.x. PMID 18983484.
  31. Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, Kolakoski M, Wilber N (July 2000). "Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators". Blood. 96 (2): 437–42. PMID 10887103.
  32. Angelini D, Sood SL (2015). "Managing older patients with hemophilia". Hematology Am Soc Hematol Educ Program. 2015: 41–7. doi:10.1182/asheducation-2015.1.41. PMID 26637699.
  33. Franchini M, Mannucci PM (October 2011). "Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice". Br J Clin Pharmacol. 72 (4): 553–62. doi:10.1111/j.1365-2125.2010.03899.x. PMC 3195733. PMID 21204915.